- Zacks•24 days ago
Genomic Health, Inc. (GHDX), a global cancer company, recently unveiled positive results regarding Oncotype DX Genomic Prostate Score (GPS).
- Investopedia•24 days ago
Genomic Health, Inc. GHDX, a global cancer company, recently unveiled positive results regarding Oncotype DX Genomic Prostate Score (GPS). The new data from a large multi-center validation study, confirmed ...
- CNW Group•25 days ago
New Research Shows Oncotype DX® Breast Cancer Test Helps Reduce Burden of Chemotherapy
GHDX : Summary for Genomic Health, Inc. - Yahoo Finance
Genomic Health, Inc. (GHDX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||31.03 - 31.59|
|52 Week Range||23.57 - 33.96|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-74.17|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|